Cost-Effectiveness Analysis of Germline and Somatic BRCA Testing in Patients With Advanced Ovarian Cancer.

Annals of laboratory medicine(2023)

引用 2|浏览15
暂无评分
摘要
Considering the importance of knowing a patient's gene status, germline testing first, followed by somatic testing, may be a reasonable option.
更多
查看译文
关键词
Advanced ovarian cancer,BRCA testing,Cost-effectiveness analysis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要